Synthetic insulin was produced in August 1978 using transgenic, genetically modified bacteria developed by Herbert Boyer. This achievement marked a shift in medical manufacturing, utilizing recombinant DNA techniques to express peptide-coding genes. By synthesizing these genes from individual nucleotides, he established a foundation for modern biotechnology and the commercialization of genetic engineering through corporate collaboration.
Academic Foundation
Born in 1936 in Derry, Pennsylvania, Herbert Boyer pursued his early education at Saint Vincent College in Latrobe, where he earned a bachelor's degree in biology and chemistry in 1958. He continued his academic progression at the University of Pittsburgh, completing his PhD in 1963. His training included three years of postdoctoral research at Yale University under Professors Edward Adelberg and Bruce Carlton. During the 1960s, he engaged in studies concerning the restriction enzymes of E. coli, identifying specific properties that would prove critical for his later work in gene manipulation.
Twenty questions, eight minutes on the clock, and a percentile measured against everyone who has taken it. No sign-up.
Take the IQ test →Genetic Engineering and Genentech
Upon joining the faculty at the University of California, San Francisco, Boyer focused on the synthesis of bacterial and eukaryotic genes. In 1976, he co-founded the firm Genentech alongside venture capitalist Robert A. Swanson. This partnership provided the framework to transition his laboratory findings into practical medical applications. While competing with other research efforts, such as those led by Walter Gilbert at Biogen, Boyer’s team successfully synthesized insulin and, by 1979, human growth hormone. He served as vice president of Genentech from 1976 until his retirement in 1991.
Institutional Recognition and Philanthropy
Boyer has received numerous accolades for his contributions to molecular biology and technology, including the Albert Lasker Award for Basic Medical Research in 1980 and the National Medal of Science in 1990. In 1990, he and his wife, Grace, provided a donation of $10,000,000 to the Yale School of Medicine, leading to the establishment of the Boyer Center for Molecular Medicine in 1991. Saint Vincent College further recognized his influence by renaming its School of Natural Science, Mathematics, and Computing to the Herbert W. Boyer School during the 2007 commencement ceremony.
Fast facts
- Born: 1936, Derry, Pennsylvania
- Education: Saint Vincent College, University of Pittsburgh
- Co-founder: Genentech
- Key Discovery: Recombinant DNA technology
- National Medal of Science recipient: 1990
- Perkin Medal recipient: 2007
- Notable role: Vice president of Genentech (1976–1991)
- Professional memberships: National Academy of Sciences
Questions readers ask
What was Herbert Boyer's main scientific contribution?
He developed recombinant DNA methods to induce bacteria to produce foreign proteins, enabling the creation of synthetic insulin and growth hormones.
Did Herbert Boyer work in industry?
Yes, he co-founded the biotechnology company Genentech in 1976 and served as its vice president until 1991.
Achievements
- Lemelson–MIT Prize — 1996
- National Medal of Technology and Innovation — 1989
- Perkin Medal — 2007
- National Medal of Science — 1990
- Albany Medical Center Prize — 2004
- Affiliated with University of California, San Francisco
- Educated at University of Pittsburgh
.jpg)
